APA (7th ed.) Citation

RS, P., O, C., HA, L., CX, M., SN, S., & ML, F. (2023). Rational Drug Design of Targeted and Enzyme-Cleavable Vitamin E Analogs as a Neoadjuvant to Chemotherapy: In Vitro and In Vivo Evaluation on Reduction of the Cardiotoxicity Side Effect of Doxorubicin. ACS pharmacology & translational science, 6(3), 372. https://doi.org/10.1021/acsptsci.2c00091

Chicago Style (17th ed.) Citation

RS, Pandurangi, Cseh O, Luchman HA, Ma CX, Senadheera SN, and Forrest ML. "Rational Drug Design of Targeted and Enzyme-Cleavable Vitamin E Analogs as a Neoadjuvant to Chemotherapy: In Vitro and In Vivo Evaluation on Reduction of the Cardiotoxicity Side Effect of Doxorubicin." ACS Pharmacology & Translational Science 6, no. 3 (2023): 372. https://doi.org/10.1021/acsptsci.2c00091.

MLA (9th ed.) Citation

RS, Pandurangi, et al. "Rational Drug Design of Targeted and Enzyme-Cleavable Vitamin E Analogs as a Neoadjuvant to Chemotherapy: In Vitro and In Vivo Evaluation on Reduction of the Cardiotoxicity Side Effect of Doxorubicin." ACS Pharmacology & Translational Science, vol. 6, no. 3, 2023, p. 372, https://doi.org/10.1021/acsptsci.2c00091.